# Phase 1 fibrosis trials recruiting: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 1 for fibrosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 fibrosis trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/fibrosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 15, 2026 | NCT07876284 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Doses of Inhaled CHF10073 in Participants With Idiopathic... | Chiesi Farmaceutici S.p.A. | Phase 1 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876284) |
| July 2, 2026 | NCT07682337 | Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects | SCBIO Inc. | Phase 1 | Not yet recruiting | Solid Tumor, Obesity, Idiopathic Pulmonary Fibrosis | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682337) |
| May 22, 2026 | NCT07604272 | Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males | Northwestern University | Phase 1 | Recruiting | Inguinal Hernia Unilateral, Inguinal Hernia Without Obstruction or Gangrene | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604272) |
| May 18, 2026 | NCT07593690 | A Phase I Study of HW241045 in Healthy Subjects | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Phase 1 | Not yet recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593690) |
| April 7, 2026 | NCT07515066 | Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for... | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07515066) |
| March 6, 2026 | NCT07454291 | A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants | Endeavor Biomedicines, Inc. | Phase 1 | Recruiting | Idiopathic Pulmonary Fibrosis | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454291) |
| February 27, 2026 | NCT07437105 | Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants | Vertex Pharmaceuticals Incorporated | Phase 1 | Recruiting | Cystic Fibrosis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07437105) |
| February 12, 2026 | NCT07407543 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males | siRNAgen Therapeutics Inc. | Phase 1 | Recruiting | Idiopathic Pulmonary Fibrosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407543) |
| January 9, 2026 | NCT07329959 | CAR-DC for End-Stage IPF | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 1 | Not yet recruiting | Idiopathic Pulmonary Fibrosis(IPF) | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07329959) |
| December 16, 2025 | NCT07283770 | Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis | Vertex Pharmaceuticals Incorporated | Phase 1 | Recruiting | Cystic Fibrosis | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07283770) |
| December 12, 2025 | NCT07280598 | Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections | University of California, San Diego | Phase 1 | Not yet recruiting | CF - Cystic Fibrosis, Klebsiella Pneumoniae Infection, E Coli Infections, Staphylococcus Aureus Infection... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07280598) |
| December 10, 2025 | NCT07275905 | Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection | Sponsor not shown (see the record) | Phase 1 | Recruiting | Cystic Fibrosis (CF), Achromobacter Infection | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07275905) |
| February 10, 2025 | NCT06817590 | Nucleoside Therapy in Patients With Telomere Biology Disorders | Sponsor not shown (see the record) | Phase 1 | Recruiting | Telomere Biology Disorders, Dyskeratosis Congenita, Revesz Syndrome, Hoyeraal Hreidarsson Syndrome, Telomere Biology... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06817590) |
| May 14, 2024 | NCT06413355 | FAPI-74 PET/CT in Adults With Fibrosis | Abramson Cancer Center at Penn Medicine | Phase 1 | Recruiting | Fibrosis (Morphologic Abnormality) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06413355) |
| March 25, 2024 | NCT06327308 | Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant. | Centre Hospitalier Universitaire de Besancon | Phase 1 | Recruiting | Cirrhosis, Registered on Transplant List | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06327308) |
| August 14, 2023 | NCT05988463 | Dose-Escalation Study of Artesunate Patients With IPF | Sponsor not shown (see the record) | Phase 1 | Recruiting | Idiopathic Pulmonary Fibrosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05988463) |
| June 29, 2023 | NCT05925036 | Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis | VA Office of Research and Development | Phase 1 | Recruiting | Chronic Pancreatitis, Chronic Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05925036) |
| April 6, 2023 | NCT05802264 | Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis | Cystetic Medicines, Inc. | Phase 1 | Recruiting | Cystic Fibrosis | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05802264) |
| August 17, 2022 | NCT05504837 | A Study Assessing KB407 for the Treatment of Cystic Fibrosis | Krystal Biotech, Inc. | Phase 1 | Recruiting | Cystic Fibrosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05504837) |
| August 8, 2022 | NCT05490888 | Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics | PharmaIN | Phase 1 | Recruiting | Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05490888) |
| November 16, 2021 | NCT05121779 | Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT | Peking Union Medical College Hospital | Phase 1 | Recruiting | Pulmonary Fibrosis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05121779) |
| September 16, 2021 | NCT05045482 | Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease | Zydus Therapeutics Inc. | Phase 1 | Recruiting | Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05045482) |
| November 10, 2020 | NCT04624490 | Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease | Sponsor not shown (see the record) | Phase 1 | Recruiting | Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, Pulmonary Infection, Other Lung... | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04624490) |
| April 27, 2020 | NCT04362644 | Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis | University of Alabama at Birmingham | Phase 1 | Recruiting | Idiopathic Pulmonary Fibrosis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04362644) |
| March 3, 2020 | NCT04294043 | IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) | Sponsor not shown (see the record) | Phase 1 | Recruiting | Nontuberculous Mycobacterium Infection | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04294043) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Vertex Pharmaceuticals Incorporated](https://specstream.ai/data/clinical-trials/company/vertex-pharmaceuticals-incorporated) | 2 |
| siRNAgen Therapeutics Inc. | 1 |
| Massachusetts General Hospital | 1 |
| University of Alabama at Birmingham | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| PharmaIN | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Cystetic Medicines, Inc. | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Endeavor Biomedicines, Inc. | 1 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 1 |
| University of California, San Diego | 1 |
| Krystal Biotech, Inc. | 1 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 1 |
| SCBIO Inc. | 1 |
| VA Office of Research and Development | 1 |
| Northwestern University | 1 |
| Peking Union Medical College Hospital | 1 |
| Zydus Therapeutics Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 15 |
| China | 3 |
| Australia | 3 |
| South Korea | 1 |
| New Zealand | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mediators in the United States](https://specstream.ai/data/businesses/mediators/united-states)
- [Indonesian restaurants in the United States](https://specstream.ai/data/businesses/indonesian-restaurants/united-states)
- [Foundation repair contractors in the United States](https://specstream.ai/data/businesses/foundation-repair-contractors/united-states)
- [E-commerce services in the United States](https://specstream.ai/data/businesses/e-commerce-services/united-states)
- [Cigar bars in the United States](https://specstream.ai/data/businesses/cigar-bars/united-states)
- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
